Explore the words cloud of the UBIMOTIF project. It provides you a very rough idea of what is the project "UBIMOTIF" about.
The following table provides information about the project.
|Coordinator Country||Denmark [DK]|
|Total cost||4˙147˙222 €|
|EC max contribution||4˙147˙222 € (100%)|
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
|Duration (year-month-day)||from 2019-12-01 to 2023-11-30|
Take a look of project's partnership.
|1||KOBENHAVNS UNIVERSITET||DK (KOBENHAVN)||coordinator||595˙044.00|
|2||INSTITUT FUR MOLEKULARE BIOLOGIE GGMBH||DE (MAINZ)||participant||758˙365.00|
|3||UPPSALA UNIVERSITET||SE (UPPSALA)||participant||563˙965.00|
|4||GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.||UK (BRENTFORD)||participant||303˙172.00|
|5||THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL||UK (LONDON)||participant||303˙172.00|
|6||UNIVERSITY OF DUNDEE||UK (DUNDEE)||participant||303˙172.00|
|7||BEACTICA THERAPEUTICS AB||SE (UPPSALA)||participant||281˙982.00|
|8||EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH||CH (ZUERICH)||participant||281˙276.00|
|9||THE HEBREW UNIVERSITY OF JERUSALEM||IL (JERUSALEM)||participant||263˙500.00|
|10||UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA||IT (ROMA)||participant||261˙499.00|
|11||TARTU ULIKOOL||EE (TARTU)||participant||232˙069.00|
A major challenge is the lack of therapeutic approaches for numerous human diseases, which poses a societal challenge. The ubiquitin system is a major promising source for novel therapeutic approaches but its potential has not been fully exploited due to limited insight and lack of researchers trained in understanding and identifying avenues to target the ubiquitin system. Ubiquitin ligases and deubiquitinating enzymes (DUBs) comprises enzymes that actively add or remove ubiquitin from proteins to regulate cell physiology. How these enzymes selectively recognize their substrates is largely unknown but an emerging theme is that a globular domain in the enzyme binds a short linear interaction motif (SLiM) in the substrate. SLiMs are short peptide motifs that constitute ideal entry points for understanding the ubiquitin system as they provide detailed insight into substrate selection and how this regulates the underlying biology. Further, SLiMs provide direct routes to therapeutic exploitation as they serve as peptide scaffolds for drug development and tools to highjack the ubiquitin system. The potential of SLiMs has not been capitalized upon because a method for efficient identification was missing, interactions between relevant partners were lacking and this has hampered training of young researchers. UBIMOTIF overcomes these barriers by exploiting novel technological advances to identify SLiMs and uniting outstanding complementary researchers and industrial partners with a common vision to provide outstanding training of early career scientist in SLiMs and the ubiquitin system. The UBIMOTIF topic provides ideal training of young researchers, as it requires a multidisciplinary and intersectorial approach providing training in multiple cutting-edge technologies. The impact of UBIMOTIF will be unprecedented insight into the ubiquitin system, novel therapeutic opportunities and a skilled workforce that can fill the exhausted pipelines of European companies.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "UBIMOTIF" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "UBIMOTIF" are provided by the European Opendata Portal: CORDIS opendata.